デフォルト表紙
市場調査レポート
商品コード
1027380

抗菌薬感受性試験 (AST) 市場 - 製品別、手法別、用途別、エンドユーザー別:2028年までの予測

Antimicrobial Susceptibility Testing Market, by Product (Manual {Susceptibility Discs, Plates, MIC Strips}, Consumables, Automated), Method (Diffusion, Dilution), Application (Clinical Diagnostics), End User - Forecast to 2028

出版日: | 発行: Meticulous Market Research Pvt. Ltd. | ページ情報: 英文 104 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.72円
抗菌薬感受性試験 (AST) 市場 - 製品別、手法別、用途別、エンドユーザー別:2028年までの予測
出版日: 2021年09月08日
発行: Meticulous Market Research Pvt. Ltd.
ページ情報: 英文 104 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の抗菌薬感受性試験 (AST) 市場は、2028年までに59億9,000万米ドルに達し、2021年~2028年のCAGRで6.4%の成長が予測されています。市場の成長は、主に感染症の増加、AST製品の自動化、多剤耐性の出現、AMRに対する資金提供や政府のイニシアチブの増加、技術の進歩、新製品の開発などに起因しています。

当レポートでは、世界の抗菌薬感受性試験 (AST) 市場について調査分析し、COVID-19の影響、市場考察、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場考察

  • イントロダクション
  • 促進要因
  • 抑制要因
  • 機会
  • 課題
  • COVID-19の影響評価

第5章 抗菌薬感受性試験 (AST) 市場:製品別

  • イントロダクション
  • 手動AST製品
  • 消耗品
  • 自動AST製品

第6章 抗菌薬感受性試験 (AST) 市場:手法別

  • イントロダクション
  • ディスク拡散法
  • 自動AST
  • 希釈法
  • その他

第7章 抗菌薬感受性試験 (AST) 市場:用途別

  • イントロダクション
  • 臨床診断
  • 創薬・開発
  • その他

第8章 抗菌薬感受性試験 (AST) 市場:エンドユーザー別

  • イントロダクション
  • 診断研究所・病院
  • 製薬・バイオテクノロジー企業
  • 研究・学術機関

第9章 抗菌薬感受性試験 (AST) 市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • その他のアジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • イントロダクション
  • 主要な成長戦略
  • 競合ベンチマーキング
  • 市場シェア分析

第11章 企業プロファイル

  • Danaher Corporation
  • Becton, Dickinson And Company
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • HiMedia Laboratories Pvt. Ltd.
  • Merlin Diagnostika GmbH
  • bioMerieux S.A
  • Merck KGaA
  • Accelerate Diagnostics, Inc.
  • Alifax S.r.l.
  • Creative Diagnostics
  • Synbiosis
  • Zhuhai Dl Biotech Co., Ltd.

第12章 付録

図表

List of Tables

  • Table 1 Global Antimicrobial Susceptibility Testing Market Drivers: Impact Analysis (2021-2028)
  • Table 2 Global Burden of Infectious Diseases (2018)
  • Table 3 Funding Scenario for Antimicrobial Susceptibility Testing
  • Table 4 List of Rapid AST Systems and Manufacturers
  • Table 5 Future Technologies for the Antimicrobial Susceptibility Testing
  • Table 6 Global Antimicrobial Susceptibility Testing Market Restraints: Impact Analysis (2021-2028)
  • Table 7 Some of the Future Technologies for Antimicrobial Susceptibility Testing
  • Table 8 Economic Analysis of the Automated AST Systems
  • Table 9 Global Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 10 Global Manual Antimicrobial Susceptibility Testing Products Market Size, by Type, 2019-2028 (USD Million)
  • Table 11 Global Manual Antimicrobial Susceptibility Testing Products Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 12 Key Companies offering Susceptibility Disks
  • Table 13 Global Susceptibility Disks Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 14 Key Companies offering Susceptibility Plates
  • Table 15 Global Susceptibility Plates Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 16 Key Companies offering MIC Strips
  • Table 17 Global MIC Strips Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 18 Key Companies offering AST Consumables
  • Table 19 Global Antimicrobial Susceptibility Testing Consumables Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 20 Automated Antimicrobial Susceptibility Testing Systems
  • Table 21 Key Companies offering Automated AST Products
  • Table 22 Global Automated Antimicrobial Susceptibility Testing Products Market Size, by Country/Region, 2019 -2028 (USD Million)
  • Table 23 Global Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 24 Comparative Features of Diffusion and Dilution Methods
  • Table 25 Testing Time for Antimicrobial Susceptibility Testing Methods
  • Table 26 Global Antimicrobial Susceptibility Testing Market Size for Disk Diffusion, by Country, 2019-2028 (USD Million)
  • Table 27 Global Antimicrobial Susceptibility Testing Market Size for Automated Antimicrobial Susceptibility Testing, by Country/Region, 2019 - 2028 (USD Million)
  • Table 28 Comparative Features of Dilution Methods
  • Table 29 Global Antimicrobial Susceptibility Testing Market Size for Dilution, by Country/Region, 2019-2028 (USD Million)
  • Table 30 Global Antimicrobial Susceptibility Testing Market Size for Other Methods, by Country/Region, 2019-2028 (USD Million)
  • Table 31 Global Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 32 Global Antimicrobial Susceptibility Testing Market Size for Clinical Diagnostics, by Country/Region, 2019-2028 (USD Million)
  • Table 33 Global Antimicrobial Susceptibility Testing Market Size for Drug Discovery and Development, by Country/Region, 2019-2028 (USD Million)
  • Table 34 Global Antimicrobial Susceptibility Testing Market Size for Other Applications, by Country/Region, 2019-2028 (USD Million)
  • Table 35 Global Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 36 Global Antimicrobial Susceptibility Testing Market Size for Diagnostic Laboratories & Hospitals, by Country/Region, 2019-2028 (USD Million)
  • Table 37 Global Antimicrobial Susceptibility Testing Market Size for Pharmaceutical & Biotechnology Companies, by Country/Region, 2019-2028 (USD Million)
  • Table 38 Global Antimicrobial Susceptibility Testing Market Size for Research and Academic Institutes, by Country/Region, 2019-2028 (USD Million)
  • Table 39 Global Antimicrobial Susceptibility Testing Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 40 North America: Antimicrobial Susceptibility Testing Market Size, by Country, 2019-2028 (USD Million)
  • Table 41 North America: Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 42 North America: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2019-2028 (USD Million)
  • Table 43 North America: Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 44 North America: Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 45 North America: Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 46 U.S.: Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 47 U.S.: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2019-2028 (USD Million)
  • Table 48 U.S.: Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 49 U.S.: Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 50 U.S.: Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 51 Canada: Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 52 Canada: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2019-2028 (USD Million)
  • Table 53 Canada: Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 54 Canada: Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 55 Canada: Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 56 Initiatives for Antimicrobial Resistance in Europe
  • Table 57 Europe: Antimicrobial Susceptibility Testing Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 58 Europe: Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 59 Europe: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2019-2028 (USD Million)
  • Table 60 Europe: Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 61 Europe: Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 62 Europe: Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 63 Germany: Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 64 Germany: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2019-2028 (USD Million)
  • Table 65 Germany: Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 66 Germany: Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 67 Germany: Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 68 U.K.: Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 69 U.K.: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2019-2028 (USD Million)
  • Table 70 U.K.: Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 71 U.K.: Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 72 U.K.: Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 73 France: Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 74 France: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2019-2028 (USD Million)
  • Table 75 France: Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 76 France: Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 77 France: Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 78 Italy: Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 79 Italy: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2019-2028 (USD Million)
  • Table 80 Italy: Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 81 Italy: Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 82 Italy: Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 83 Spain: Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 84 Spain: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2019-2028 (USD Million)
  • Table 85 Spain: Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 86 Spain: Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 87 Spain: Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 88 RoE: Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 89 RoE: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2019-2028 (USD Million)
  • Table 90 RoE: Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 91 RoE: Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 92 RoE: Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 93 Asia-Pacific: Antimicrobial Susceptibility Testing Market Size, by Country/Region, 2019-2028 (USD Million)
  • Table 94 Asia-Pacific: Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 95 Asia-Pacific: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2019-2028 (USD Million)
  • Table 96 Asia-Pacific: Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 97 Asia-Pacific: Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 98 Asia-Pacific: Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 99 China: Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 100 China: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2019-2028 (USD Million)
  • Table 101 China: Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 102 China: Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 103 China: Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 104 Japan: Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 105 Japan: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2019-2028 (USD Million)
  • Table 106 Japan: Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 107 Japan: Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 108 Japan: Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 109 India: Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 110 India: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2019-2028 (USD Million)
  • Table 111 India: Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 112 India: Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 113 India: Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 114 RoAPAC: Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 115 RoAPAC: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2019-2028 (USD Million)
  • Table 116 RoAPAC: Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 117 RoAPAC: Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 118 RoAPAC: Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 119 Latin America: Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 120 Latin America: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2019-2028 (USD Million)
  • Table 121 Latin America: Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 122 Latin America: Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 123 Latin America: Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 124 Estimated Global Deaths Due To AMR by 2050
  • Table 125 Middle EAST & Africa: Antimicrobial Susceptibility Testing Market Size, by Product, 2019-2028 (USD Million)
  • Table 126 Middle EAST & Africa: Manual Antimicrobial Susceptibility Testing Market Size, by Type, 2019-2028 (USD Million)
  • Table 127 Middle EAST & Africa: Antimicrobial Susceptibility Testing Market Size, by Method, 2019-2028 (USD Million)
  • Table 128 Middle EAST & Africa: Antimicrobial Susceptibility Testing Market Size, by Application, 2019-2028 (USD Million)
  • Table 129 Middle EAST & Africa: Antimicrobial Susceptibility Testing Market Size, by End User, 2019-2028 (USD Million)
  • Table 130 Number of Developments by the Major Players during 2018-2021

List of Figures

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-Side& Demand-Side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global Antimicrobial Susceptibility Testing Market Size, by Product, 2021 Vs 2028 (USD Million)
  • Figure 8 Global Antimicrobial Susceptibility Testing Market Size, by Method, 2021 Vs 2028 (USD Million)
  • Figure 9 Global Antimicrobial Susceptibility Testing Market Size, by Application, 2021 Vs 2028 (USD Million)
  • Figure 10 Global Antimicrobial Susceptibility Testing Market Size, by End User, 2021 Vs 2028 (USD Million)
  • Figure 11 Antimicrobial Susceptibility Testing Market Size, by Geography
  • Figure 12 Market Dynamics
  • Figure 13 Global Antimicrobial Susceptibility Testing Market Size, by Product, 2021-2028 (USD Million)
  • Figure 14 Global Antimicrobial Susceptibility Testing Market Size, by Method, 2021-2028 (USD Million)
  • Figure 15 Global Antimicrobial Susceptibility Testing Market Size, by Application, 2021-2028 (USD Million)
  • Figure 16 Global Burden of Infectious Diseases (2018)
  • Figure 17 Antibacterial Agents in Clinical Development, 2019
  • Figure 18 Global Antimicrobial Susceptibility Testing Market Size, by End User, 2021-2028 (USD Million)
  • Figure 19 Estimated Global R&D Spending On Pharmaceuticals
  • Figure 20 List of New Molecular Entity Approvals (NME) Per Year
  • Figure 21 Global Antimicrobial Susceptibility Testing Market Size, by Geography, 2021-2028 (USD Million)
  • Figure 22 North America: Antimicrobial Susceptibility Testing Market Snapshot
  • Figure 23 U.S.: Candida Bloodstream Infections, by Species
  • Figure 24 No. of Cases of Drug-Resistant Candida In Hospitalized Patients in the U.S.
  • Figure 25 Europe: Antimicrobial Susceptibility Testing Market Snapshot
  • Figure 26 Italy: Deaths Due To Antimicrobial Resistance (2015-2050)
  • Figure 27 Asia-Pacific: Antimicrobial Susceptibility Testing Market Snapshot
  • Figure 28 Key Growth Strategies Adopted by Leading Players -2018-2021
  • Figure 29 Antimicrobial Susceptibility Testing Market: Competitive Benchmarking (Based On Product)
  • Figure 30 Global Antimicrobial Susceptibility Testing Market Share, by Key Players, 2020 (%)
  • Figure 31 Danaher Corporation: Financial Overview (2020)
  • Figure 32 Becton, Dickinson And Company: Financial Overview (2020)
  • Figure 33 Bio-Rad Laboratories, Inc.: Financial Overview (2020)
  • Figure 34 Thermo Fisher Scientific Inc: Financial Overview (2020)
  • Figure 35 Bruker Corporation: Financial Overview (2020)
  • Figure 36 bioMerieux S.A: Financial Overview (2020)
  • Figure 37 Merck KGaA: Financial Overview (2020)
  • Figure 38 Accelerate Diagnostics, Inc.: Financial Overview (2020)
  • Figure 39 SDI Group plc: Financial Overview (2020)
目次
Product Code: MRHC - 104363

Antimicrobial Susceptibility Testing Market by Product (Manual {Susceptibility Discs, Plates, MIC Strips}, Consumables, Automated), Method (Diffusion, Dilution), Application (Clinical Diagnostics), End User (Hospitals, Pharma, Institutes) - Forecast to 2028

The global antimicrobial susceptibility testing market is expected to grow at a CAGR of 6.4% from 2021 to 2028 to reach $5.99 billion by 2028.

Succeeding an extensive secondary and primary research and in-depth analysis of the market scenario, the report carries out the key industry drivers, restraints, challenges, and opportunities. The antimicrobial susceptibility testing market's growth is mainly attributed to growth in infectious diseases, development of automated AST products, the emergence of multidrug resistance, increased funding and government initiatives for AMR and technological advancements, and new product developments. Active R&D to develop rapid antimicrobial susceptibility testing and growth prospects in emerging markets are offering market opportunities.

Based on product, the manual AST products segment is estimated to account for the largest share of the market in 2021. Higher adoption of manual techniques compared to automated due to their cost-effectiveness and ease of processing is a key factor supporting market growth. Further manual AST products are segmented into susceptibility discs, susceptibility plates, and minimum inhibitory concentration (MIC) test strips. Based on the type of manual AST products, the susceptibility discs segment is estimated to account for the largest share of the market in 2021.

Based on method, the automated AST products segment is expected to create several opportunities for market growth. The key factor attributing to the market growth is the emerging need to obtain the same-day antimicrobial susceptibility testing results to determine the treatment of a wide range of infectious diseases. Automated AST provides streamlined workflows and quantitative results. Further, accurate and precise measurements and enhanced performance offered by automated AST also support market growth.

Based on application, the clinical diagnostics segment is expected to account for the largest share of the antimicrobial susceptibility testing market in 2021 due to the rising burden of antimicrobial resistance and growing awareness about the use of antimicrobial susceptibility testing methods.

An in-depth analysis of the geographical scenario of the antimicrobial susceptibility testing (blood samples) market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is estimated to command the largest share of the global antimicrobial susceptibility testing market in 2021, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Rising antibiotic resistance and increasing government initiatives to fight antibiotic resistance are the major factors driving the growth of the antimicrobial susceptibility testing (blood sample) market in North America. Further, the increased prevalence of potentially fatal bloodstream infections caused by antimicrobial-resistant organisms also positively impacts the market growth.

Some of the key players operating in the global antimicrobial susceptibility testing market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMerieux S.A. (France), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories Pvt. Ltd. (India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China).

Scope of the Report:

Global Antimicrobial Susceptibility Testing Market, by Product

  • Manual Antimicrobial Susceptibility Testing Products
    • Susceptibility Discs
    • Susceptibility Plates
    • Minimum Inhibitory Concentration (MIC) Strips
  • Consumables
  • Automated Antimicrobial Susceptibility Testing Products

Global Antimicrobial Susceptibility Testing Market, by Method

  • Disc Diffusion
  • Automated AST
  • Dilution
  • Other Methods

Other methods include Etest, genotypic methods, and MALDI-TOF MS.

Global Antimicrobial Susceptibility Testing Market, by Application

  • Clinical Diagnostics
  • Drug Discovery and Development
  • Other Applications

Other applications include epidemiology, veterinary diagnostic, and environmental monitoring

Global Antimicrobial Susceptibility Testing Market, by End User

  • Diagnostic Laboratories and Hospitals
  • Pharmaceutical and Biotechnology Companies
  • Research and Academic Institutes

Global Antimicrobial Susceptibility Testing Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Bottom-Up Approach
    • 2.3.2. Top-Down Approach
    • 2.3.3. Growth Forecast
  • 2.4. Assumptions for This Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Introduction
  • 4.2. Drivers
    • 4.2.1. High Prevalence of Infectious Diseases
    • 4.2.2. Development of Automated and Manual AST Products
    • 4.2.3. Emergence of Multidrug Resistance
    • 4.2.4. Increased Funding and Government Initiatives
    • 4.2.5. Technological Advancements towards the Development of Rapid AST Methods
  • 4.3. Restraints
    • 4.3.1. Stringent Government Regulations
  • 4.4. Opportunities
    • 4.4.1. Active R&D to Develop Rapid Antimicrobial Susceptibility Testing
    • 4.4.2. Emerging Markets
  • 4.5. Challenges
    • 4.5.1. High Cost of Automated Antimicrobial Susceptibility Testing
    • 4.5.2. Issues in AMR Surveillance in Low-Income and Middle-Income Countries
  • 4.6. Covid-19 Impact Assessment

5. Antimicrobial Susceptibility Testing Market, by Product

  • 5.1. Introduction
  • 5.2. Manual Antimicrobial Susceptibility Testing Products
    • 5.2.1. Susceptibility Disks
    • 5.2.2. Susceptibility Plates
    • 5.2.3. Minimum Inhibitory Concentration (MIC) Strips
  • 5.3. Consumables
  • 5.4. Automated Antimicrobial Susceptibility Testing Products

6. Global Antimicrobial Susceptibility Market, by Method

  • 6.1. Introduction
  • 6.2. Disk Diffusion
  • 6.3. Automated Antimicrobial Susceptibility Testing
  • 6.4. Dilution
  • 6.5. Other Methods

7. Global Antimicrobial Susceptibility Testing Market, by Application

  • 7.1. Introduction
  • 7.2. Clinical Diagnostics
  • 7.3. Drug Discovery and Development
  • 7.4. Other Applications

8. Global Diagnostic Antibody Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostic Laboratories & Hospitals
  • 8.3. Pharmaceutical & Biotechnology Companies
  • 8.4. Research & Academic Institutes

9. Global Antimicrobial Susceptibility Testing Market, by Geography

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. U.K.
    • 9.3.3. France
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe (RoE)
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. India
    • 9.4.4. Rest of Asia-Pacific (RoAPAC)
  • 9.5. Latin America
  • 9.6. Middle East & Africa

10. Competitive Landscape

  • 10.1. Introduction
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Market Share Analysis
    • 10.4.1. Biomerieux S.A. (France)
    • 10.4.2. Thermo Fisher Scientific Inc. (U.S.)
    • 10.4.3. Danaher Corporation (U.S.)

11. Company Profiles

  • 11.1. Danaher Corporation
    • 11.1.1. Business Overview
    • 11.1.2. Financial Overview
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Developments
  • 11.2. Becton, Dickinson And Company
    • 11.2.1. Business Overview
    • 11.2.2. Financial Overview
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Developments
  • 11.3. Bio-Rad Laboratories, Inc.
    • 11.3.1. Business Overview
    • 11.3.2. Financial Overview
    • 11.3.3. Product Portfolio
  • 11.4. Thermo Fisher Scientific Inc.
    • 11.4.1. Business Overview
    • 11.4.2. Financial Overview
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Developments
  • 11.5. HiMedia Laboratories Pvt. Ltd.
    • 11.5.1. Business Overview
    • 11.5.2. Product Portfolio
  • 11.6. Merlin Diagnostika GmbH
    • 11.6.1. Business Overview
    • 11.6.2. Financial Overview
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Developments
  • 11.7. bioMerieux S.A
    • 11.7.1. Business Overview
    • 11.7.2. Financial Overview
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Developments
  • 11.8. Merck KGaA
    • 11.8.1. Business Overview
    • 11.8.2. Financial Overview
    • 11.8.3. Product Portfolio
  • 11.9. Accelerate Diagnostics, Inc.
    • 11.9.1. Business Overview
    • 11.9.2. Financial Overview
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Developments
  • 11.10. Alifax S.r.l.
    • 11.10.1. Business Overview
    • 11.10.2. Product Portfolio
    • 11.10.3. Strategic Developments
  • 11.11. Creative Diagnostics
    • 11.11.1. Business Overview
    • 11.11.2. Product Portfolio
  • 11.12. Synbiosis
    • 11.12.1. Business Overview
    • 11.12.2. Financial Overview
    • 11.12.3. Product Portfolio
    • 11.12.4. Strategic Developments
  • 11.13. Zhuhai Dl Biotech Co., Ltd.
    • 11.13.1. Business Overview
    • 11.13.2. Product Portfolio
    • 11.13.3. Strategic Developments

12. Appendix

  • 12.1. Questionnaire
  • 12.2. Available Customization